01/14/25 Minority communities need access to GLP-1s. Congress and President-elect Trump must deliver.
Over the past few years, GLP-1s like Ozempic and Wegovy have become household names. Prescriptions for these medications have skyrocketed in the United States, from just over 131,000 between 2015 and 2018 to more than 679,000 between 2019 and 2023. These drugs are popular for good...